Page 5 - Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 27, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

127 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4195

Genomics BioSci & Tech.Ltd
NT$18.001.1%-13.7%NT$1.3bn/aPS3.1xn/a0%

6936

Vetnostrum Animal Health
NT$37.80-0.3%-0.5%NT$2.5bn/an/an/a2.8%

6949

Pell Bio-Med Technology
NT$86.50-3.7%n/aNT$5.0bn/aPS271.1xn/an/a

6917

Andros PharmaceuticalsLtd
NT$18.8015.3%-23.7%NT$653.7mn/an/an/an/a

6939

TFBS Bioscience
NT$37.800%-27.0%NT$1.3bn/an/an/a0.1%

6549

TaiwanJ Pharmaceuticals
NT$9.02-5.2%-45.7%NT$722.7mn/aPB12.6xn/an/a

6712

Ever Supreme Bio Technology
NT$174.00-0.9%-3.3%NT$14.0bn/aPE55.2xn/a3.1%

7607

DuoGenic StemCells
NT$27.60-4.2%-21.6%NT$843.3mn/an/an/an/a

6575

SyneuRx International (Taiwan)
NT$17.200%-69.6%NT$2.1bn/aPB7.7xn/an/a

1271

SunWay Biotech
NT$83.40-4.9%-5.4%NT$5.0bn/aPE49.7xn/a1.2%

4131

NeoCore Technology
NT$29.904.0%30.3%NT$1.2bn/aPS17.3xn/an/a

4186

Taiwan Advance Bio-Pharmaceutical
NT$15.701.9%-7.9%NT$1.4bn/aPE66xn/an/a

6976

Acepodia
NT$17.800%-43.8%NT$10.2bn/aPS602xn/an/a

4726

Mycenax Biotech
NT$44.15-3.3%20.3%NT$9.1bn/aPS13.5xn/an/a

4174

OBI Pharma
NT$62.10-2.1%-24.8%NT$14.2bn/aPS204.7xn/an/a

4172

InnoPharmax
NT$19.553.2%-12.7%NT$1.9bn/aPS53.7xn/an/a

7595

Pharmigene
NT$14.00-7.9%-39.1%NT$706.5mn/aPS5.6xn/an/a

4120

Orient EuroPharma
NT$48.701.1%23.4%NT$4.2bn/aPE22.1xn/a2.1%

1734

Sinphar PharmaceuticalLtd
NT$31.00-0.6%-0.8%NT$5.7bn/aPE16.9xn/a3.0%

4102

Yung Zip Chemical Ind
NT$32.754.6%-16.1%NT$1.4bn/aPE16xn/a2.4%

6645

Kim Forest Enterprise
NT$27.40-2.0%-36.8%NT$1.5bn/aPS3.2xn/a0.3%

6945

AP Biosciences
NT$50.00-0.4%-3.7%NT$4.2bn/aPS131.6xn/an/a

4746

Formosa Laboratories
NT$75.00-5.2%-26.1%NT$9.0bNT$117.50PE23xS7.8%2.7%

7561

Bioray Biotech
NT$20.302.5%-28.8%NT$605.6mn/aPS3.3xn/a0%
Page 5 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.